InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: Learning53 post# 153320

Wednesday, 03/17/2021 7:32:16 PM

Wednesday, March 17, 2021 7:32:16 PM

Post# of 233144

best-in-class lifesaving drug


Notice not one scientist has agreed except for CytoDyn associated people? The trial as a whole failed. 390 is a very small trial. A slight benefit to a 62 patient slice is irrelevant to the FDA and anyone who understands science. And the 24% benefit in the tiny 62 patient portion would be reversed if 2 more placebo patients had lived out of 19 placebo patients. If you know a scientist or doctor in your real life, ask them about the results. Their response will not be positive.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News